Chairman
Glenmark Pharmaceuticals Limited
Equibles does not estimate personal net worth.
Glenn Saldana is recorded as Chairman at Glenmark Pharmaceuticals Limited. Glenn Saldana has spoken on 1 earnings call across 1 company, most recently for Glenmark Pharmaceuticals Limited on August 3, 2026. Glenmark Pharmaceuticals Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“We've begun FY27 on a very strong note, delivering consolidated YOY revenues of 23%. Even if you exclude the deferred income from 2001, the base business YOY growth is north of 18%.”
Glenmark Pharmaceuticals Limited
Chairman
Transcript header (unverified)
Glenmark Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Chairman
Earnings Call for the Quarter Ended June 30, 2026
Glenmark Pharmaceuticals Limited
